• Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives Consensus Rating of "Moderate Buy" from Brokerages

    Source: Buzz FX / 19 Feb 2025 01:36:11   America/Chicago


    Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat February 19, 2025 Share Link copied to clipboard. Shares of Sangamo Therapeutics, Inc.
    Read more...
Share on,